Adagio Medical Holdings Inc ADGM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia
-
Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress
-
Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference
-
Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System
Trading Information
- Previous Close Price
- $0.53
- Day Range
- $0.51–0.54
- 52-Week Range
- $0.51–2.58
- Bid/Ask
- $0.54 / $0.62
- Shares Outstanding
- 22.21M
- Market Cap
- $11.77M
- Volume/Avg
- 35,429 / 100,338
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- —
- Total Number of Employees
- 41
- Website
- https://www.adagiomedical.com
Valuation
|
Metric
|
ADGM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.06 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ADGM
|
|---|---|
Quick Ratio | 1.51 |
Current Ratio | 1.85 |
Interest Coverage | −7.20 |
Quick Ratio
ADGM
Profitability
|
Metric
|
ADGM
|
|---|---|
Return on Assets (Normalized) | −58.97% |
Return on Equity (Normalized) | −297.86% |
Return on Invested Capital (Normalized) | −70.27% |
Return on Assets
ADGM
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|X?CR&d | LOCK|gsvmw | $175B | |||
| Stryker Corp
SYK
| LOCK|mHjMy&! | LOCK|Yjy | $123B | |||
| Medtronic PLC
MDT
| LOCK|j^<pG@h | LOCK|M<H& | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|z$LyMW | LOCK|GCr< | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|&w^?>$X | LOCK|cGPVd | $49B | |||
| DexCom Inc
DXCM
| LOCK|g!<nw!rP | LOCK|^&T$% | $30B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|C!&D&! | LOCK|>>L | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|<& | LOCK|<Hz | $26B | |||
| Steris PLC
STE
| LOCK|%X><?^ | LOCK|N$V? | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|<JNY@<>% | LOCK|NwC | $18B |
United States